Bio/Pharma Outsourcing Innovation eBook
Read the article: Scaling Manufacturing Processes Using Single-Use Technologies
Read the eBook:
Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook
Scaling Manufacturing Processes Using Single-Use Technologies
By Kai Lipinski
News
Article
Pharmaceutical TechnologyPharmaceutical Technology, Bio/Pharma Outsourcing Innovation, February 2023
Volume 2023 eBook
Issue 1
Pages: 16-21
Although new single-use technologies offer the flexibility needed to overcome several challenges in ATMP production, there are many considerations and hurdles manufacturers must be aware of when scaling.
RGtimeline - Stock.adobe.com
Since biological drugs first became available, their demand has been increasing—with the biologic market being valued at approximately US$302.63 billion in 2020 and expecting to reach US$509.23 billion by 2026 at a compound annual growth rate of 9.06% (1). With advancements in research and technologies, the diversity of biological drugs available is broad, including monoclonal antibodies (mAbs), prophylactic vaccines, gene therapy viral vectors (mainly lentivirus and adeno-associated virus), cell therapies (e.g., chimeric antigen receptor T-cell therapy and modified stem cells), and oncolytic viruses (e.g., adenoviruses, herpes viruses, and vaccinia virus).
As a result, the bioreactor vendor and contract development and manufacturing organization industries are under pressure to increase production scale. To meet demand, these industries must feasibly scale up while considering safety, manual operator handling, engineering, infrastructure, costs, and finally biological processing itself.
Read this article in Pharmaceutical Technology's February 2023 Bio/Pharma Outsourcing Innovation eBook.
About the author
Kai Lipinski, PhD, is the chief scientific officer of Vibalogics.
Article details
Pharmaceutical Technology
eBook: Bio/Pharma Outsourcing Innovation
February 2023
Pages: 16-21
Citation
When referring to this article, please cite it as Lipinski, K. Scaling Manufacturing Processes Using Single-Use Technologies. Pharmaceutical Technology's Bio/Pharma Outsourcing Innovation eBook (February 2023).
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
